Latest return on equity
Mineralys Therapeutics Return on equity
Direct answer
Mineralys Therapeutics's return on equity is -80.88%.
The verified market snapshot reports -80.88%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 7, 2026.
Get free Mineralys Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -80.88%
Explore related company data
View Mineralys Therapeutics's market capitalizationView Mineralys Therapeutics's price-to-book ratioView Mineralys Therapeutics's 52-week price rangeView Mineralys Therapeutics's profit marginView Mineralys Therapeutics's debt-to-equity ratioView all Mineralys Therapeutics key metricsReturn to Mineralys Therapeutics profile